Karen Broder, M.D. Epidemic Intelligence Service Officer

Slides:



Advertisements
Similar presentations
2010 National Immunization Survey Report, Texas Child and Teen Vaccination Coverage Levels Jack Sims-Immunization Branch Manager Tony Aragon, MS-Epidemiologist.
Advertisements

Causing Bacterial Meningitis
An Approach to Demonstration of Effectiveness
Liza Chapman, Pharm.D. GPhA Annual Meeting
DR SWATI PRASHANT MD Paediatrics Index Medical College,Indore,MP,India.
Bacterial Meningitis What you need to know to protect yourself.
Introduction of New vaccines Hib as an Example St. Petersburg Jun 2001.
RPMS Immunization Package Training - Reports Version 8.5*1 Amy Groom, MPH IHS Immunization Program Manager.
A Child 2 years or older entering Preschool or Head Start 4 Diphtheria/Tetanus/Pertussis (DTaP) 3 Polio 1 Varicella (chickenpox) – if no history of disease.
Diseases Caused by Bacteria
The Facts about this Infection!
Public Health Preventive Medicine primary prevention specific prevention immunization Samar Musmar,MD,FAAFP Consultant, family medicine Clinical assistant.
What's New on the Child and Adolescent Immunization Schedules William L. Atkinson, MD, MPH National Center for Immunization and Respiratory Diseases William.
1 1 Immunization Update 2011 Connecticut Immunization Teleconference April 19, 2011 William Atkinson, MD, MPH National Center for Immunization and Respiratory.
Splenectomy Vaccine Protocol PIDPIC Rationale Spleen clears encapsulated bacteria and infected erythrocytes Serves as one of the largest lymphoid.
Immunoprevention. Definition By using immunological agents to construct, improve or inhibit immune response, people can prevent some diseases.
Kristine Sheedy, PhD Associate Director for Communication Science National Center for Immunization and Respiratory Diseases The Importance of Effective.
Bacterial Meningitis By Dana Burkart.
Haemophilus influenzae type B and Hib Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease.
Economic Evaluation of Routine Childhood Immunization with DTaP, Hib, IPV, MMR and HepB Vaccines in the United States, 2001 Fangjun Zhou Health Services.
August 20, 2003 Focus Area 14: Immunization and Infectious Diseases Progress Review.
30th anniversary of starting EPI
Bacterial Meningitis Allie Gray. Bacterial and Viral Meningitis are very different.
State Affiliate Challenge 1 South Dakota School Nurses Association Florida Association of School Nurses Delaware School Nurse Association.
5th Annual Advocacy Project: ImmuneWise Section on Medical Students, Residents, and Fellowship Trainees
Better Health. No Hassles. Get Immunized! National Immunization Month.
What is immunization Immunization is the process of conferring increased resistance (or decrease susceptibility) to infection.
American Academy of Pediatrics, Committee on Infectious Diseases. Policy Statement—Recommendations for Prevention and Control of Influenza in Children,
Chris Knefelkamp, PharmD PGY2 Internal Medicine Resident Richard L. Roudebush VA Medical Center September 17, 2015 A SHOT IN THE DARK: PNEUMOCOCCAL PNEUMONIA.
IMMUNIZATIONS, PART I Janine Clark Adjo, M.D IMMUNIZATION SCHEDULE.
“Immunizations” What Parents Should Know. The Immune System DEFINITION: Body’s method of protecting itself from foreign substances that invade the body.
1 Vaccines and Related Biological Products Advisory Committee Meeting November 18, 2009 Questions for the Committee Prevnar 13 Pneumococcal 13-valent Conjugate.
Visibility of Vaccination and How Do We Improve?
Bacterial meningitis among children with cochlear implants
Bacterial Meningitis and Cochlear Implants
Thomas Weiser, MD, MPH Medical Epidemiologist Portland Area Indian Health Service Northwest Portland Area Indian Health Board.
MANDATORY CHILDHOOD IMMUNIZATIONS AND ADOLESCENT HUMAN PAPILLOMAVIRUS (HPV): NO SHOTS – NO SCHOOL AUDREY MUNN AMY ROELSE.
TM Centers for Disease Control and Prevention National Center on Birth Defects and Developmental Disabilities Centers for Disease Control and Prevention.
Note to presenter: The National Immunization Program can provide a videotape with animated sequences illustrating the biology of active and passive immunity.
Note to presenters: Images of vaccine-preventable diseases are available from the Immunization Action Coalition website at
American Academy of Pediatrics, Committee on Infectious Diseases. Policy Updated Recommendations on the Use of Meningococcal Vaccines Pediatrics. doi:
CAUSING BACTERIAL MENINGITIS Cochlear Implants. Cochlear Implant Is a surgically implanted device that helps overcome problems in the inner ear, or cochlea.
What is a vaccine? A vaccine is a medicine that's given to help prevent a disease. Vaccines help the body produce antibodies. These antibodies protect.
OEREP Journal Club: December 5, 2012 “Vaccines are medicine’s bright and shining star, before, parents in the United States could expect each year “Vaccines.
 Carolyn A. Parry, MPH CDC Public Health Advisor Montana Immunization Program 2016 Regional Immunization Workshops.
Ocean State Immunization Collaborative 2016 State - Supplied Vaccine Workshop May 17, 2016.
1 13-valent pneumococcal conjugate vaccine (PCV13) – new ACIP recommendations 44 th National Immunization Conference April 21, 2010 Pekka Nuorti, MD, DSc.
Haemophilus influenzae type B and Hib Vaccine
+ Head to Toe and Places in Between April 21, 2016 Lance Chilton, MD Winona Stoltzfus, MD.
Date of download: 6/21/2016 From: Recommended Adult Immunization Schedule: United States, October 2007–September 2008(1) Ann Intern Med. 2007;147(10):
Pneumococcal Disease and Pneumococcal Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory.
The Impact of Vaccines: Personal Stories Women in Government Learning Exchange on Adult Vaccine Policies August 1, 2017 Diane C Peterson Immunization.
Diseases Caused by Bacteria
Beatriz E Builes, Cindy Weinbaum, Abigail Shefer,
Ann Intern Med. 2007;147(10): doi: / Figure Legend:
What’s Up With All Those Other Vaccines?
New Immunization Education Products
Megan Kral Public Service Health Announcement January 28, 2015
Prevention of illneses: vaccination
Emerging Gaps in Financing for New Vaccines
Recommended Timeline for Influenza Vaccinations
Vaccines Vaccines are given to prevent, or minimize the severity of, disease Vaccination elicits an immune response which has “memory”
Vaccines.
Combination and Special Circumstance Vaccines
Preventing Meningococcal B Disease
Immunization Throughout the Life Course: What Is the Clinician's Role?
Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes  S. Ladhani,
Racial and ethnic disparities in childhood immunization rates have declined as overall coverage increased. Percentage of children ages 19 to 35 months.
Healthy People 2010 Focus Area 14
Influenza algorithm for determining recommended 2009–2010 influenza immunization. a Contraindications: please refer to page 7 of the policy statement for.
Presentation transcript:

Bacterial Meningitis Vaccines and the Prevention of Meningitis in Cochlear Implant Recipients Karen Broder, M.D. Epidemic Intelligence Service Officer National Immunization Program Centers for Disease Control and Prevention February 24, 2003

US Meningitis Vaccines Haemophilus influenzae Type b Conjugate (Hib) (several brands) Meningococcal Polysaccharide (Menomune®) Pneumococcal Polysaccharide (Pneumovax®) Pneumococcal Conjugate (Prevnar®)

US Vaccination Policy

Recommended Childhood and Adolescent Immunization Schedule, US 2003 Vaccine Age Birth 1 mo 2 mos 4 Hepatitis B1 Diphtheria, Tetanus, Pertussis2 Haemophilus influenzae Type b3 Inactivated Polio Measles, Mumps, Rubella4 Varicella5 Pneumococcal6 Hepatitis A7 Influenza8 HepB #1 HepB #2 4-6 yrs 6 12 15 18 24 11-12 13-18 HepB #3 DTaP Td Hib IPV MMR #1 MMR #2 Varicella PCV Hepatitis A series Influenza (yearly) Vaccines below this line are for selected populations range of recommended ages catch-up vaccination HepB series PPV only if mother HBsAg ( - ) preadolescent assessment http://www.cdc.gov/nip/recs/child-schedule.htm

Haemophilus influenzae Type b (Hib) Vaccine Universal immunization for children aged <5 years High-risk indications for persons aged ≥5 years Immune system disorders

Meningococcal Vaccine Not universal immunization High-risk indications usually for persons aged ≥2 years Travel to endemic country Outbreak control College Freshman living in dorm (often optional) Immune system disorders

Pneumococcal Polysaccharide Vaccine (PPV23) Universal immunization for adults aged ≥65 years High-risk indications for persons aged 2-64 years Immune system disorders Residence in special environments or social settings Chronic medical conditions

Chronic Medical Conditions with PPV23 Indication Cardiovascular disease Pulmonary disease (not asthma) Diabetes mellitus Alcoholism Chronic liver disease Cerebrospinal fluid (CSF) leaks

Pneumococcal Conjugate Vaccine (PCV7) Universal immunization for children aged <2 years High-risk indications for children aged 2-4 years Moderate-risk considerations for children aged 2-4 years

PCV7 High-Risk Indications Children Aged <5 Years Immune system disorders Chronic medical conditions Similar to PPV23, including CSF leaks

PCV7 Vaccine Supply National Vaccine Shortage

Public Health Response Meningitis Vaccination and Cochlear Implant Recipients Reviewed meningitis vaccination recommendations Disseminated vaccination information to stakeholders Cochlear implant recipients State health departments Health care providers

Immunization Response to Cochlear Implants and Meningitis Association Could vaccination decrease the risk of meningitis among cochlear implant recipients?

Review of Vaccination Policy Vaccine-preventable cause? Yes, pneumococcus Biological plausibility? Yes, potential anatomic pathways and other mechanisms

Review of Vaccination Policy Applicable ACIP high-risk indication? Yes, pneumococcal vaccination for persons with CSF leaks Accessibility concerns? Yes, national PCV7 vaccine shortage

CDC Recommendation for Cochlear Implant Recipients: High-Risk Pneumococcal Vaccination

Information Resources Cochlear Implants and Vaccination NIP Website General public http://www.cdc.gov/nip/issues/cochlear/cochlear-gen.htm Health care provider http://www.cdc.gov/nip/issues/cochlear/ cochlear-hcp.htm National Immunization Hotline English (800)232-2522 Spanish (800)232-0233 TTY (800)243-7889

Pneumococcal Vaccination Schedule for Unvaccinated Cochlear Implant Recipients Age in Years PCV7* PPV23** <2 √ 2-4 ≥5 * ACIP Age-appropriate high-risk schedules should be followed ** PPV23 and PCV7 should be administered ≥ 2 months apart.

Vaccination for Cochlear Implant Recipients Four bacterial meningitis vaccines covering three causes of meningitis No initial specific vaccination recommendations Current pneumococcal vaccination recommendations Following study need to reevaluate vaccination recommendations

Acknowledgments Cochlear Implant Team including: J. Reefhuis, M. Honein, S. Chamany, K. Biernath, C. Whitney, E. Mann, S. Manning, S. Avashia, M. Victor, B. Culpepper, P. Costa, and C. Boyle Immunization Team including: J. Moran, B. Schwartz, T. Murphy, K. Bisgard, M. Wharton, L. Pickering, M. Bailey, the State Immunization Coordinators and the National Immunization Hotline